Invesco Biotechnology & Genome ETFPBE

InvescoSectorsTechnology#30 of 264 by YTD

$104.67

+2.3% last session

+28.8% YTD

Data as of 11/4/20264:00 PM ET · End-of-day

Dividend-adjusted total return · S&P 500 uses VOO · Dec 31, 2025 – Nov 4, 2026PBES&P 500 · VOO

Returns	1D	1M	3M	YTD	1Y	3Y	5Y	MAX
Total return	+2.3%	+10.5%	+14.9%	+28.8%	+42.4%	+102.2%	+44.3%	+485.7%
Peer average	+0.8%	−8.7%	−4.9%	+9.4%	+6.0%	+90.4%	+35.2%	—
S&P 500 · VOO	+1.6%	−1.6%	0.0%	+13.4%	+13.5%	+91.7%	+81.2%	—

Key Statistics

Open all fund facts →

AUM: $435M
Expense ratio: 0.59%
Distribution yield: 1.3%
NAV: $101.00
Volume: 18K
Avg. volume 30D: 15K
High today: $104.69
Low today: $102.12
Previous close: $102.34
52-week high: $104.69
52-week low: $73.16
Our risk indicator: 4/5

PBE in One Breath

PBE Among Technology ETFs

YTD

#1GNOMGlobal X+54.5%$109M

#2PSCTInvesco+37.2%$475M

#3FBTFirst Trust+35.3%$3.1B

#4IBBiShares+31.1%$11.2B

#5IBBQInvesco+31.0%$120M

#6PBEInvesco+28.8%$435M

#7SPTESP Funds+28.1%$243M

#8SNSRGlobal X+27.0%$196M

#9IXNiShares+26.4%$8.8B

End-of-day Nov 5, 2026 · 54 Technology ETFs by YTD

$10,000 in PBE

$10,000 in PBE became

$14,427

In the S&P 500 (VOO)

$18,115

Total return, dividends in · Oct 27, 2021 – Nov 4, 2026 · S&P 500 uses VOO

PBE’s Top Holdings

Today

REGN5.6%NTRA5.6%BIIB5.4%GILD5.4%RPRX5.2%ILMN5.1%AMGN5.0%VRTX4.6%MRNA3.8%EXEL3.3%HALO3.1%UTHR3.0%19 more

BiotechnologyMedical - DiagnosticsDrug Manufacturers - GeneralMedical - PharmaceuticalsMedical - Instruments

Invesco PBE · 31 holdings · tile size = share of the fund · as of Nov 4, 2026

What PBE Holds

Today

Biotechnology57.4%

REGN 5.6 · VRTX 4.6 · MRNA 3.8 · EXEL 3.3 · HALO 3.1 · UTHR 3.0 · TGTX 2.9

Medical - Diagnostics & Research16.7%

NTRA 5.6 · ILMN 5.1 · QGEN 3.0 · VCYT 3.0

Drug Manufacturers - General15.9%

BIIB 5.4 · GILD 5.4 · AMGN 5.0

Medical - Pharmaceuticals5.2%

RPRX 5.2

Medical - Instruments & Supplies2.6%

RGEN 2.6

Drug Manufacturers - Specialty & Generic2.3%

COLL 2.3

Asset Management0.0%

AGPXX

Invesco PBE · share of the fund by industry · as of Nov 4, 2026

Regeneron’s Share of PBE

Today

5.6%

$56 of every $1,000 in PBE is Regeneron

Regeneron held by PBE

$24.5M

Most Regeneron per dollar

BBH8.0%

IBB6.6%

SGRT6.6%

IBBQ6.3%

Invesco PBE · each square = $10 of $1,000 · as of Nov 4, 2026

PBE’s Share of Technology ETFs

Today

0.1%

of the $366B in 58 Technology ETFs

PBE$435M0.1%

VGT$155B42.3%

XLK$115B31.5%

55 others$95.6B26.2%

Technology ETF AUM · Nov 5, 2026

PBE Fee per $100 vs Peers

Today

$0.59a year
per $100

$59 a year on $10,000

XLK$0.08

FTEC$0.08

VGT$0.09

IYW$0.37

IBB$0.44

PBE$0.59

Expense ratio · Technology peers · Nov 5, 2026

Inside PBE

31 holdings · as of Nov 4, 2026

PBE

Invesco Biotechnology & Genome ETF

Today

Biotechnology57.4%REGN5.6%VRTX4.6%MRNA3.8%EXEL3.3%HALO3.1%UTHR3.0%TGTX2.9%NBIX2.8%NVAX2.7%LEGN2.6%SRPT2.6%VCEL2.5%PTGX2.4%PTCT6 more holdings12.9% of the fundMedical - Diagnostics16.7%NTRA5.6%ILMN5.1%QGEN3.0%VCYT3.0%Drug Manufacturers - General15.9%BIIB5.4%GILD5.4%AMGN5.0%Medical - Pharmaceuticals5.2%RPRX5.2%Medical - Instruments2.6%RGEN2.6%Drug Manufacturers - Specialty2.3%COLL

Biotechnology57.4%REGN5.6%VRTX4.6%MRNA3.8%EXELHALOUTHR14 more holdings33.9% of the fundMedical - Diagnostics16.7%NTRA5.6%ILMN5.1%QGEN3.0%VCYT3.0%Drug Manufacturers - General15.9%BIIB5.4%GILD5.4%AMGNMedical - Pharmaceuticals5.2%RPRX5.2%RGENCOLL

#	Ticker	Company	Weight ▼
1	REGN	Regeneron Pharmaceuticals	5.62%
2	NTRA	Natera	5.56%
3	BIIB	Biogen	5.43%
4	GILD	Gilead Sciences	5.42%
5	RPRX	Royalty Pharma	5.15%
6	ILMN	Illumina	5.10%
7	AMGN	Amgen	5.02%
8	VRTX	Vertex Pharmaceuticals	4.62%
9	MRNA	Moderna	3.78%
10	EXEL	Exelixis	3.35%

BiotechnologyMedical - DiagnosticsDrug Manufacturers - GeneralMedical - PharmaceuticalsMedical - InstrumentsDrug Manufacturers - SpecialtyAsset Management

Invesco PBE · current holdings by weight · as of Nov 4, 2026 · each tile is one holding · top 20 = 77.4%

How It Compares

PBE

Invesco Biotechnology & Genome ETF’s Peers


VGT	VanguardRead Desk	0.09%	+16.7%	+23.1%	$154.5B
XLK	SPDRRead Desk	0.08%	+17.5%	+23.0%	$115.0B
IYW	iSharesRead Desk	0.37%	+15.5%	+20.7%	$23.5B
FTEC	FidelityRead Desk	0.08%	+16.7%	+23.1%	$22.1B
IBB	iSharesRead Desk	0.44%	+40.7%	+31.1%	$11.2B
PBE	InvescoThis fundRead Desk	0.59%	+42.4%	+28.8%	$435M

Technology peers · Past-year and ytd returns · as of Nov 5, 2026 · sorted by AUM

Head to Head

Put PBE head to head with VGT →

VGT vs PBE

YTD

VGTVanguard · TechnologyPBEInvesco · Technology

Year to date

+23.1%

+28.8%

PBE wins+5.7 pts

Past year

+16.7%

+42.4%

PBE wins+25.7 pts

Fee

0.09%

0.59%

VGT winslower fee

Yield

0.4%

1.3%

PBE wins+0.9 pts

AUM

$155B

$435M

VGT354.9× more

3–1PBE wins

Vanguard VGT and Invesco PBE · year-to-date · as of Nov 5, 2026 · AUM not scored

PBE vs VOO

PBE · Invesco Biotechnology & Genome

+42.4%

VOO · S&P 500

+13.5%

Gap

28.9 pts

Invesco PBE and Vanguard VOO · 1Y total return · as of Nov 5, 2026

PBE vs Its Peer Average

YTD

PBEAvsBPeer average

1D+2.3%+0.8%

1M+10.5%−8.7%

3M+14.9%−4.9%

YTD+28.8%+9.4%

1Y+42.4%+6.0%

3Y+102.2%+90.4%

5Y+44.3%+35.2%

7–0PBE wins

57 Technology peers · each row scaled to its leader

The Details

PBE

Risk

4/5our risk indicator

CalmerBumpier

Volatility · 1Y19.92%

Deepest drop · 1Y−11.7%

Lowest point · 5Y−29.5%

52-week range

$104.67

$73.16at the high$104.69

Invesco PBE · past-year price moves · as of Nov 5, 2026

PBE

Fund Facts

Today

2005launched Jun 23

Tracks[…]

Exchange · CUSIPAMEX · 46137V787

StructureETF

Leverage1x

Cost on $10,000$59 a year

Go deeper

Prospectus & documents Trading & liquidity Fees & costs Distributions

Invesco PBE · fund facts · as of Nov 5, 2026

PBE

Payouts by Year

10Y

$0.0187per share, Sep 2026

Distribution yield1.3%

PaidEvery quarter

Latest ex-date · paidSep 21 · Sep 25, 2026

12 payouts added up$1.81 a share

Invesco PBE · distributions by ex-date · 2014–2026

All Fund FactsDocuments · trading · fees · every payout

Prospectus & Documents

SEC reported portfolio · 2026-07-31 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2026-04-30 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2026-01-31 ↗SEC reported portfolio · 2025-10-31 ↗SEC reported portfolio · 2025-07-31 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2025-04-30 ↗SEC reported portfolio · 2025-01-31 ↗SEC reported portfolio · 2024-10-31 ↗SEC reported portfolio · 2024-07-31 ↗summary prospectus · SEC 497K ↗

Trading & Liquidity

Net asset value$101.00

Premium / discount[…]

Median spread · 30D[…]

Volume today18K

Average volume · 30D15K

Shares outstanding[…]

Options[…]

Fees & Costs

Net expense ratio0.59%

Gross expense ratio[…]

Management fee[…]

Cost on $10,000 a year$59.00

Our risk indicator4/5

Estimated yearly cost excludes trading costs and assumes constant assets.

Distributions

Ex-date	Paid	Per share
Sep 21, 2026	Sep 25, 2026	$0.0187
Jun 22, 2026	Jun 26, 2026	$0.81
Mar 23, 2026	Mar 27, 2026	$0.0824
Dec 22, 2025	Dec 26, 2025	$0.42
Sep 22, 2025	Sep 26, 2025	$0.23
Jun 23, 2025	Jun 27, 2025	$0.13
Mar 24, 2025	Mar 28, 2025	$0.0341
Jun 24, 2024	Jun 28, 2024	$0.0082
Mar 18, 2024	Mar 22, 2024	$0.0242
Jun 20, 2023	Jun 23, 2023	$0.0141
Mar 23, 2020	Mar 31, 2020	$0.0290
Sep 24, 2018	Sep 28, 2018	$0.0021

Issuer contentFrom InvescoHear the strategy from the people behind PBE.No issuer videos have been published for this fund.Are you the issuer? Claim this fund →